Skip to main content
Terug
Watch Compare

X4 Pharmaceuticals, Inc

Datakwaliteit: 100%
XFOR
Nasdaq Manufacturing Chemicals
€ 4,05
€ 0,00 (0,00%)
Marktkapitalisatie: 368,22 M
Prijs
€ 4,05
Marktkapitalisatie
368,22 M
Dagbereik
€ 3,99 — € 4,16
52-Weeksbereik
€ 1,35 — € 6,90
Volume
248.891
Openen € 4,02
50D / 200D Gem.
€ 3,75
8,06% above
50D / 200D Gem.
€ 3,28
23,33% above

Quick Summary

Belangrijkste Punten

Negative free cash flow of -85,62 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)154,20%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-241,50%
Onder sectorgemiddelde (-53,47%)
ROIC-61,75%
Net Margin-1218,45%
Op. Margin-1336,66%

Veiligheid

Debt / Equity
1,22
Boven sectorgemiddelde (0,31)
Current Ratio5,65
Interest Coverage-9,79

Waardering

PE (TTM)
-4,65
Onder sectorgemiddelde (-1,47)
P/B Ratio5,98
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -4,7 -1,5
P/B 6,0 1,6
ROE % -241,5 -53,5
Net Margin % -1218,5 -41,5
Rev Growth 5Y % — 1,8
D/E 1,2 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 154,20% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 6,50 M Net Income (TTM) -79,20 M
ROE -241,50% ROA -58,94%
Gross Margin N/A Operating Margin -1336,66%
Net Margin -1218,45% Free Cash Flow (TTM) -85,62 M
ROIC -61,75% FCF Growth (3Y) N/A
Safety
Debt / Equity 1,22 Current Ratio 5,65
Interest Coverage -9,79 Asset Turnover 0,05
Working Capital 109,30 M Tangible Book Value 34,83 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4,65 Forward P/E N/A
P/B Ratio 5,98 P/S Ratio 56,65
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -23,25%
Market Cap 368,22 M Enterprise Value 373,59 M
Per Share
EPS (Diluted TTM) -1,87 Revenue / Share 0,07
FCF / Share -0,94 OCF / Share -0,94
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 108,10%
SBC-Adj. FCF -90,07 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 6,50 M 2,56 M — 0,0 0,0
Net Income -79,20 M -37,45 M -101,17 M -93,87 M -88,70 M
EPS (Diluted) -1,87 -0,19 -0,57 -1,52 —
Gross Profit — — — — —
Operating Income -86,88 M -36,40 M -107,52 M -87,57 M -85,11 M
EBITDA — — — — —
R&D Expenses 72,72 M 81,64 M 72,02 M 61,06 M 50,65 M
SG&A Expenses — — — — —
D&A 1,28 M 796.000,0 419.000,0 513.000,0 499.000,0
Interest Expense 8,88 M 8,77 M 5,78 M 3,99 M 3,64 M
Income Tax 41.000,0 310.000,0 78.000,0 28.000,0 17.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 290,46 M 146,45 M 147,26 M 155,59 M 117,18 M
Total Liabilities 104,17 M 124,30 M 96,16 M 81,54 M 52,76 M
Shareholders' Equity 186,29 M 22,15 M 51,10 M 74,05 M 64,41 M
Total Debt 75,00 M 75,00 M 55,00 M 32,50 M 32,50 M
Cash & Equivalents 217,05 M 55,70 M 99,22 M 121,72 M 81,79 M
Current Assets 261,58 M 112,18 M 122,08 M 128,68 M 87,88 M
Current Liabilities 25,76 M 32,88 M 22,86 M 22,32 M 14,02 M